Literature DB >> 3131830

The induction of chromosome aberrations during the course of radiation therapy for morbus Hodgkin.

A Diener1, G Stephan, T Vogl, J Lissner.   

Abstract

In a patient with Morbus Hodgkin, structural aberrations of the chromosome type in peripheral lymphocytes were analyzed during radiation therapy (accumulated target dose 44.6 Gy: 22 fractions of 1.8 Gy each and 2 fractions of 2.5 Gy each at the end of the therapy). The blood was sampled about 5 min after a fraction and/or 24, 48, or 72 h thereafter. The frequency of dicentric chromosomes:acentric fragments:centric ring chromosomes is 37:14:1 throughout the therapy. Independent of the time of blood sampling after a fraction, the distributions of dicentrics and acentrics are overdisperse and represent negative binomial distributions. The yields from these aberrations, as determined during the course of radiotherapy, are best fitted to a linear-quadratic function with a negative quadratic term. The two dose-effect curves (blood sampling about 5 min and 24 to 72 h after a fraction) of dicentrics and acentrics do not differ significantly. Up to an accumulated target dose of about 20 Gy the percentages of cells with chromosome aberrations increase to about 48 to 65% and, at this level, remain constant until the end of therapy.

Entities:  

Mesh:

Year:  1988        PMID: 3131830

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  3 in total

1.  Comparison of the micronucleus and chromosome aberration techniques for the documentation of cytogenetic damage in radiochemotherapy-treated patients with rectal cancer.

Authors:  Hendrik Andreas Wolff; Steffen Hennies; Markus Karl Alfred Herrmann; Margret Rave-Fränk; David Eickelmann; Patricia Virsik; Klaus Jung; Markus Schirmer; Michael Ghadimi; Clemens Friedrich Hess; Robert Michael Hermann; Hans Christiansen
Journal:  Strahlenther Onkol       Date:  2010-12-23       Impact factor: 3.621

2.  Cytogenetic assessment of heterogeneous radiation doses in cancer patients treated with fractionated radiotherapy.

Authors:  S Roch-Lefèvre; F Pouzoulet; A L Giraudet; Pa Voisin; A Vaurijoux; G Gruel; E Grégoire; V Buard; M Delbos; Ph Voisin; J Bourhis; L Roy
Journal:  Br J Radiol       Date:  2010-09       Impact factor: 3.039

3.  Transcriptional Dynamics of DNA Damage Responsive Genes in Circulating Leukocytes during Radiotherapy.

Authors:  Lourdes Cruz-Garcia; Farah Nasser; Grainne O'Brien; Jakub Grepl; Volodymyr Vinnikov; Viktor Starenkiy; Sergiy Artiukh; Svetlana Gramatiuk; Christophe Badie
Journal:  Cancers (Basel)       Date:  2022-05-26       Impact factor: 6.575

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.